DCGI recommends Covovax as heterologous booster dose

Jan 12, 2023

The Central drug regulatory authority Drugs Controller General of India (DCGI) has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as...

Bharat Biotech's nasal Covid vaccine for adults gets Centre's nod, to be availabile in private hospitals

Dec 23, 2022

Bharat Biotech's nasal vaccine - iNCOVACC has been approved by the Government of India and will be used as a heterologous booster dose for...

NTAGI to discuss inclusion of Covovax in CoWIN portal as heterologous booster dose soon

Jan 18, 2023

The National Technical Advisory Group on Immunisation (NTAGI) is likely to meet soon to discuss inclusion of Covid vaccine Covovax on the CoWIN portal...

Bharat Biotech's intranasal heterologous booster dose likely to hit market in February first week

Jan 23, 2023

According to the company, the price of iNCOVACC will be Rs 900 for the private market and Rs 325 for supplies to the Government...

NTAGI holds meeting on Covovax inclusion as heterologous booster on CoWin portal

Feb 09, 2023

National Technical Advisory Group on Immunisation conducted a meeting on February 8 regarding the inclusion of Covid19 vaccine Covovax as a heterologous booster dose...

Corbevax likely to be available at vaccination centres from tomorrow

Aug 11, 2022

Hyderabad (Telangana) [India], August 11 : The recently approved heterologous Covid-19 vaccine, Corbevax is expected to be available as a booster dose on the...